Bladder control therapy
Axonics: the test-drive-first implant for bladder control
By the time someone searches for Axonics, they have usually been through the bladder drills: cutting caffeine, timed bathroom trips, pelvic floor exercises, and one or two medications that either did not work or were not tolerable. Axonics is a brand of sacral neuromodulation — a small implanted device that steadies the nerve signals between bladder and brain — and it occupies a specific place in care: a third-line therapy you can fully test before committing to. This guide explains how the therapy works, the trial phase, how Axonics compares with InterStim and bladder Botox, what living with the implant involves, the honest complication picture, and how coverage works.
Last reviewed: June 9, 2026
Quick answer
Axonics is an implanted device that treats overactive bladder, urgency incontinence, and bowel leakage by gently stimulating the sacral nerves near the tailbone, which steadies the miscommunication between bladder and brain. It is a third-line therapy — used after behavioral changes and medications fall short — and it has a built-in advantage: you trial the stimulation with a temporary lead first, and only proceed to the implant if your symptoms improve by at least half. Modern versions are small, last roughly 10 to 20 years, and allow full-body MRI scans.
What shapes whether Axonics is appropriate, and what it costs
What you have already tried
Axonics sits at the third line of overactive bladder care. Insurers and guidelines expect documented attempts at behavioral measures and medication first, so the path — and the coverage — runs through that history being in your chart.
The trial phase result
Before any permanent implant, a temporary test phase measures whether stimulation actually helps you, tracked with a bladder diary. At least 50 percent improvement is the standard bar to proceed, which means the implant decision is based on your own measured result, not a prediction.
Rechargeable versus recharge-free
Axonics makes a rechargeable model and a recharge-free model. Recharge-free means no maintenance but eventual replacement; rechargeable means a brief charging routine and potentially longer service life. The right choice depends on your preferences and dexterity.
Insurance and Medicare criteria
Sacral neuromodulation is covered by Medicare and most commercial plans when third-line criteria are met and the trial succeeds. Preauthorization is standard, and the practice should confirm both the trial and the implant are approved before scheduling.
Who does the procedure and how often
Lead placement technique influences how well the therapy works and how long it lasts without revision. A urologist or urogynecologist who implants these regularly — and offers the alternatives like Botox and PTNS — gives you a recommendation driven by fit rather than habit.
What Axonics is and how sacral neuromodulation works
Overactive bladder is usually a signaling problem: the bladder reports urgency to the brain too early and too loudly. Sacral neuromodulation places a thin lead next to the third sacral nerve, just above the tailbone, where a gentle electrical pulse steadies that traffic — most patients feel either nothing or a faint flutter once it is programmed.
Axonics is the company that re-energized this therapy with a miniaturized device, long battery life, and MRI compatibility; Medtronic's InterStim is the original competitor. The therapy itself — where the lead goes and what it does — is essentially the same idea in both.
It is a control system, not a cure: symptoms typically return if the device is turned off, and settings get adjusted over time with a small remote. For the right patient, studies show large, durable reductions in urgency episodes and leaks, with most implanted patients maintaining their response for years.
Who it helps: the moment medications stop being the answer
Axonics is FDA-approved for urgency urinary incontinence, urgency-frequency syndrome, fecal (bowel) incontinence, and non-obstructive urinary retention. The common thread is a nerve-signaling problem that behavioral measures and medications could not adequately quiet.
The typical candidate has tried bladder training and at least one or two medications — anticholinergics or mirabegron — and stopped because they did not work or because of dry mouth, constipation, blood pressure, or memory concerns. Guidelines and insurers treat that step as the gateway to third-line therapy.
It is not for everyone with leakage. Stress incontinence — leaking with coughs, lifting, or exercise — is a different mechanism with different treatments, and blockage-related retention needs the blockage treated. This is why the workup, sometimes including bladder testing called urodynamics, matters before any implant conversation.
The test phase: you try the therapy before you commit
Sacral neuromodulation is one of the few surgical therapies you get to test-drive. In the trial phase, a thin temporary lead is placed near the sacral nerve — usually under local anesthesia or light sedation — and connects to a small external stimulator you wear for several days to a few weeks.
You keep a bladder diary before and during the trial, counting urgency episodes, bathroom trips, and leaks. The standard bar to proceed is at least a 50 percent improvement. If you hit it, you have personal evidence the implant will help; if you do not, the lead comes out and you have lost little.
Ask which trial style the practice uses — a quick office-based test or a staged trial using the permanent lead — and how they will measure your result. A practice that hand-waves the diary is skipping the part that protects you.
The implant procedure and living with the device
If the trial succeeds, the implant is placed during a short outpatient procedure: the lead sits next to the sacral nerve and connects to a stimulator about the size of a small stopwatch, in a pocket under the skin of the upper buttock. Most people return to light activity within days, with bending and stretching restrictions for a few weeks while the lead settles.
Day to day, the device runs silently and you adjust it with a small remote. The recharge-free model needs no maintenance until replacement; the rechargeable model needs a wireless charging session roughly monthly, an hour or so at a time. Published device specifications put service life in the range of roughly 10 to 20 years depending on model and settings.
Modern Axonics systems are approved for full-body MRI under defined conditions — a question worth confirming for your specific model — and airport security and household electronics are non-issues in normal life.
Axonics versus InterStim versus Botox: the real decision
Axonics versus InterStim is mostly a details decision now. Both offer rechargeable and recharge-free options, both are MRI-compatible in current versions, and head-to-head outcome differences are not dramatic. Device size, battery specifics, remote design, and — practically — which system your surgeon implants regularly tend to decide it.
Axonics versus Botox is the more meaningful fork. Botox avoids an implant and works well for urgency incontinence, but it wears off and repeats every six to nine months, each round carries a small risk of temporary self-catheterization, and years of injections add up in visits and copays. Neuromodulation costs more upfront, then runs quietly for years and is adjustable rather than repeatable.
Many insurers and urologists reasonably frame it as: needle-averse but surgery-tolerant patients lean neuromodulation; surgery-averse patients lean Botox; and patients who want neither can try PTNS first. Your trial-phase result, bowel symptoms (where neuromodulation also helps), and how you feel about maintenance are the tiebreakers.
Side effects, problems, and removability
The common issues are mechanical rather than dangerous: discomfort at the implant site, stimulation that feels too strong or shifts with position (usually fixed with reprogramming), and lead movement that can dull the effect. Infection is uncommon but real, as with any implanted device, and a minority of patients need a revision procedure over the years.
Published revision and explant rates are meaningful but minority numbers — worth asking your surgeon to quote their own. The honest framing: most patients keep their improvement for years; a minority need maintenance surgery along the way.
Two reassurances worth knowing. The system is adjustable — many "it stopped working" situations are programming visits, not operations. And it is removable: if the therapy disappoints or you simply want out, the device and lead can be explanted, which makes this one of the few bladder surgeries that is genuinely reversible.
Cost, insurance, and finding the right implanter
Sacral neuromodulation is an expensive device with established coverage: Medicare and most commercial plans pay for the trial and implant when third-line criteria are documented and the trial shows at least 50 percent improvement. Out-of-pocket cost then depends on your deductible and the facility setting, so ask the practice for the full picture — trial, implant, facility, and anesthesia — in writing.
Cash-pay or denied-coverage situations deserve a direct conversation: the device and facility together commonly run well into five figures, which is exactly why the documentation-driven insurance path matters.
Experience is the last variable. Lead placement quality drives results, so ask how many systems the urologist implants per year, which brands they offer, their revision rate, and whether they also offer Botox and PTNS. A directory search for an overactive-bladder or incontinence specialist gets you to the right kind of implanter — someone choosing the therapy that fits you rather than the one they happen to stock.
Axonics versus the other third-line bladder options
Axonics sacral neuromodulation
Urgency incontinence, urgency-frequency, non-obstructive retention, and bowel leakage. Testable before committing, reversible, with a device lasting roughly 10 to 20 years and full-body MRI compatibility.
Do I meet third-line criteria, and what improvement did my trial phase actually show?
InterStim (Medtronic)
The original sacral neuromodulation system, with the longest track record. Current versions are also MRI-compatible, in rechargeable and recharge-free forms. Differences from Axonics are now incremental — size, battery details, programming.
Does this practice implant both brands, and if not, is the recommendation about my fit or their inventory?
Bladder Botox injections
Effective for urgency incontinence without surgery — but it wears off, so injections repeat roughly every six to nine months, and a small percentage of patients temporarily need to self-catheterize after treatment.
Would I rather repeat injections indefinitely or have one implant procedure with occasional reprogramming?
PTNS (tibial nerve stimulation)
Nerve stimulation through an acupuncture-like needle at the ankle. No surgery at all, but it requires twelve weekly office visits, then maintenance sessions, and its effect is usually milder.
Can I commit to the visit schedule, and is a milder, no-surgery option worth trying first?
Staying on medication or combining approaches
Reasonable when symptoms are tolerable, side effects are manageable, or surgery is unappealing. But years of anticholinergic medication carry their own concerns, which is worth an honest conversation.
If medication is only partly working, what is the long-term plan — and the long-term cost — of staying on it?
Related decision guides
Overactive bladder doctor near me
The OAB workup — and the medication steps insurers expect first — start with this visit.
Urinary incontinence doctor near me
Sorting urgency leakage from stress leakage decides whether Axonics is even the right conversation.
Urodynamics test near me
Bladder testing often precedes third-line therapy decisions like neuromodulation.
Urologist for frequent urination near me
If frequency is the main complaint, start with the evaluation that explains why.
Questions to bring to the visit
How long does the Axonics battery last?
Published specifications put service life at roughly 10 to 20 years depending on the model and your stimulation settings — the recharge-free version eventually gets replaced in a short procedure, while the rechargeable version trades a brief monthly charging routine for potentially longer life. Your programmed settings change the math, so ask for an estimate based on your own programming.
Is the Axonics implant MRI safe?
Current Axonics systems are approved for full-body MRI under defined conditions, which was one of the company's major selling points. Confirm the specific model you would receive and carry your device card; the MRI facility will check the conditions before scanning.
What is the difference between Axonics and InterStim?
They are competing brands of the same therapy. Both now offer rechargeable and recharge-free, MRI-compatible systems, and outcome differences are incremental rather than dramatic. Device size, battery details, remote design, and your surgeon's experience with each brand usually decide it.
Is Axonics better than Botox for overactive bladder?
Neither is universally better; trials show broadly comparable symptom control. Botox avoids surgery but wears off and repeats every six to nine months with a small risk of temporary self-catheterization each round. Neuromodulation is one procedure that then runs for years, is adjustable, also treats bowel leakage, and can be tested before you commit.
Does insurance or Medicare cover Axonics?
Yes, when third-line criteria are met: documented overactive bladder or retention, failed or intolerable conservative measures and medications, and a successful trial phase showing at least 50 percent improvement. Preauthorization is standard, so have the practice verify the trial and implant separately before scheduling.
What are the risks and problems with Axonics?
The realistic issues are implant-site discomfort, stimulation that needs reprogramming, lead movement that dulls the effect, uncommon infection, and a minority chance of needing a revision procedure over the years. Many problems are fixed in a programming visit rather than an operation — and the system can be removed entirely if needed.
Can Axonics be removed if it does not work?
Yes. The stimulator and lead can be explanted, which makes sacral neuromodulation genuinely reversible — and the trial phase exists precisely so most people who would not benefit never get the implant in the first place.
New Jersey appointment path
Discuss Axonics and bladder control options with a urologist
Start with the practice directly. Do not send sensitive medical details through public forms; the office can move the conversation into the right intake process.